CBD is short for Cannabidiol, one of the many cannabinoids present in the Cannabis plant.
Unlike THC, CBD has no known psychoactive properties, and will not get ‘high’. What CBD does have, is an array of health benefits.
CBD is able to control inflammation, improve immune function, and ensure homeostasis (balance) in the body.
As a result, it can be used to treat a variety of diseases and illnesses due to its healing properties.
Our body already produces cannabinoids, and is full of cannabinoid receptors. This is called the Endocannabinoid System.
The receptors are CB1 and CB2 and it is likely that we have more, that are yet to be discovered.
- CB1 receptors are mainly concentrated in the brain and central nervous system, responsible for movement, coordination, pain, sensory perception, emotion, memory, cognition, autonomic and endocrine functions, to name a few.
- CB2 receptors are mainly located in the peripheral organs, and the immune system, responsible for reducing inflammation.
Given that our body produces cannabinoids, we can differentiate between two types: the endogenous (originating from within the organism) and exogenous (coming from the outside, i.e. plants).
Phytocannabinoids (plant-based cannabinoids) reproduce the effect that our endocannabinoids have on us, thus acting in a completely natural way together with our body.
Although CBD has little direct effect on CB1 and CB2 receptors, therefore producing no psychoactive effect like THC, CBD activates other non-cannabinoid receptors and ion channels.
As a result, it is able to yield all of these healing benefits and have no side effects, as opposed to conventional pharmaceuticals.
CBD Oil has been billed as the next big solution for a wide-range of health conditions. Findings suggest the active ingredient could be useful for treating a certain symptom associated with skin conditions such as eczema and psoriasis.
Cannabinoids contain anti-inflammatory properties that could also make them useful in the treatment of a wide-range of skin diseases, according to researchers at the University of Colorado Anschutz Medical Campus.
The study, published in the Journal of the American Academy of Dermatology, summarises the current literature on the subject and concludes that pharmaceuticals containing cannabinoids may be effective against eczema, psoriasis, atopic and contact dermatitis.
For more details, please visit: Link